Originally published by our sister publication Gastroenterology & Endoscopy News
This story was updated on July 30 with a comment from a gastroenterologist.
The FDA has approved vonoprazan (Voquenza, Phathom) 10-mg tablets for use in patients with nonerosive reflux disease. It can also be used with amoxicillin or amoxicillin-clavulanate to treat Helicobacter pylori infections in adults.
"This approval introduces a new option for practitioners to add to their armamentarium, said